2021
DOI: 10.2196/24522
|View full text |Cite
|
Sign up to set email alerts
|

Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study

Abstract: Background Incomplete suicidality coding in administrative claims data is a known obstacle for observational studies. With most of the negative outcomes missing from the data, it is challenging to assess the evidence on treatment strategies for the prevention of self-harm in bipolar disorder (BD), including pharmacotherapy and psychotherapy. There are conflicting data from studies on the drug-dependent risk of self-harm, and there is major uncertainty regarding the preventive effect of monotherapy … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…Here, we only highlighted a few more recent studies incorporating machine learning approaches. Nestsiarovich et al [ 174 ] proposed to use supervised machine learning (classification) to impute self-harm cases that were significantly under-reported in EHRs. They demonstrated that using the combined coded and imputed cohort, the power of their analysis could be enhanced.…”
Section: Current Challenges Trends and Future Directionsmentioning
confidence: 99%
“…Here, we only highlighted a few more recent studies incorporating machine learning approaches. Nestsiarovich et al [ 174 ] proposed to use supervised machine learning (classification) to impute self-harm cases that were significantly under-reported in EHRs. They demonstrated that using the combined coded and imputed cohort, the power of their analysis could be enhanced.…”
Section: Current Challenges Trends and Future Directionsmentioning
confidence: 99%
“…The treatment of BD is complex because different medications are needed for each phase of the disorder and may differ in the acute and in the maintenance phase [11]. The treatment of bipolar depression is a big challenge because there are few drugs with proven efficacy and the use of antidepressants is controversial [12][13][14], due to the risk for manic switch [15] and the higher risk of suicidal ideation [16,17]. Nevertheless, antidepressants, either in monotherapy or in combination with other psychotropic medications, constitute the treatment of first choice for MDD and for bipolar depression, although on average only about 40 to 60% of treated patients show a significant improvement of symptoms [18,19], with about one third of patients resistant to antidepressants [20].…”
Section: Introductionmentioning
confidence: 99%